# OnCo record nct06134232 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06134232/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06134232", "NCT06134232" ;
  schema:name "Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T"@en ;
  schema:alternateName "ProvONE"@en ;
  schema:description "A phase 2 trial of Sipuleucel-T in prostate cancer, run by Dendreon, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06134232/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06134232> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-10-02" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/sipuleucel-t/> ;
  onco:companies <https://onco.cc/companies/dendreon/> .